PURA - Puration To Issue Progress Report On 2019 $4 Million CBD Beverage Sales Target
October 03 2019 - 3:35PM
InvestorsHub NewsWire
PURA – Puration To Issue Progress
Report On 2019 $4 Million CBD Beverage Sales Target
Dallas, TX -- October 3, 2019 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) has already today confirmed the coming release next week
of new information from a recent CBD beverage industry survey
conducted on behalf of the company by Goldman Small Cap Research
(see more on PURA analyst coverage below) in conjunction with the
company’s initiative to launch new CBD Infused beer, coffee and tea
beverages. After Goldman releases the new CBD beverage
industry survey information, PURA plans to publish an update on the
launch of TranquiliTeaCBD and a new coffee infused with
CBD in addition to including a progress update on the company’s
progress toward its 2019 $4 million sales
milestone.
PURA has reported over $1 million in CBD
beverage sales in the first six months of 2019 after reporting
approximately $1 million in sales for all of 2018. PURA has
targeted a $4 million sales milestone for 2019 and on top of its
ongoing sales has signed a new European distribution agreement anticipated to
generate $4 million annually with a first shipment scheduled
later this month
PURA Goldman Small Cap Research
Coverage
Yesterday, Goldman Small Cap Research
issued an “Alert” follow-up to its recent Research Analyst Report
issued on PURA published on September 25th, 2019 (report
link below). The Research Analyst Report was triggered by the
previously mentioned CBD Beverage Industry Survey conducted on
behalf of PURA. The “Alert” issued yesterday is a confirmation of
the original investment recommendations and highlights investment
new opportunities (alert link
below).
To see the full trade alert issued today,
follow the link below:
PURATION, Inc. ALERT – October 2,
2019
To see the full
Analyst Report issued last week, follow the link
below:
PURAITON, Inc. Research Analyst Report – September
25, 2019
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024